Shawn Patrick Griffin

Health Sciences Associate Clinical Professor, Department of Clinical Pharmacy Practice
School of Pharmacy & Pharmaceutical Sciences

Leukemia, stem cell transplant, cellular therapy, pharmacotherapy, dosing of medications in obesity, graft versus host disease, supportive care

Shawn P. Griffin, PharmD, BCOP, is a Health Sciences Associate Clinical Professor in the Department of Clinical Pharmacy Practice at the UC Irvine School of Pharmacy & Pharmaceutical Sciences, where he also serves as Faculty Lead in PharmD Student Professional Development. He is a Board Certified Oncology Pharmacist in the Hematopoietic Stem Cell Transplantation and Cellular Therapy Program at the UCI Chao Family Comprehensive Cancer Center. Dr. Griffin earned his PharmD with Distinction from the University of North Carolina Eshelman School of Pharmacy and completed PGY1 and PGY2 Hematology/Oncology residencies at UF Health Shands. His research centers on pharmacokinetics in stem cell transplantation and outcomes in acute lymphoblastic leukemia, and he has authored more than 30 peer-reviewed publications. He teaches across the PharmD curriculum, precepts residents and students, and mentors research trainees. He is active in leadership with the American College of Clinical Pharmacy and the Hematology/Oncology Pharmacy Association.

Griffin SP, Signorelli JR, Lasko A, Andrick BJ, Doan D, Hough S, Riebandt G, Harnicar S. Oncology pharmacy practice in the United States: Results of a comprehensive, nationwide survey. Journal of Oncology Pharmacy Practice. 2023;Epub ahead of print. doi: 10.1177/10781552231174858.

Lee BJ, Kongtim P, Doh J, Griffin SP, Chan A, O'Brien S, Ciurea SO, Jeyakumar D. Impact of triple intrathecal prophylaxis in acute lymphoblastic leukemia adults receiving HyperCVAD: A COVID-19 practice change. European Journal of Haematology. 2023; Epub ahead of print. doi: 10.1111/ejh.13980.

Vittayawacharin P, E'Leimat G, Lee BJ, Griffin SP, Doh J, Nam H, Blodget E, Jeyakumar D, Kongtim P, Ciurea SO. Once-daily foscarnet is effective for human herpesvirus 6 reactivation after hematopoietic stem cell transplantation. Transplantation and Cellular Therapy. 2023;S2666-6367(4):1132-6. doi: 10.1016/j.jtct.2023.02.022.

Lee BJ, Griffin SP, Doh J, Kongtim P, Chan A, O’Brien S, Jeyakumar D, Ciurea SO. Timing of intrathecal chemotherapy and blinatumomab impacts neurotoxicity in acute lymphoblastic leukemia. American Journal of Hematology. Published online. doi: 10.1002/ajh.26880.

Lee BJ, Griffin SP, Doh J, Chan A, O’Brien S, Jeyakumar D, Ciurea SO, Becker PS, Kongtim P. CD19-directed immunotherapy use in KMT2A-rearranged acute leukemia: A case report and literature review of increased lymphoid to myeloid lineage switch. American Journal of Hematology. 2022;97(12):E439-43. doi: 10.1002/ajh.26713.

Benitez LL, Perissinotti AJ, Rausch CR, Klaus J, Clark SM, Filtz M, Ratermann K, Treptow C, Griffin SP, Olson M, Crain M, Kadia T, Pettit K, Burke PW, Bixby DL, Marini BL. Multicenter comparison of high-dose cytarabine based regimens versus liposomal daunorubicin and cytarabine (CPX-351) in patients with secondary acute myeloid leukemia. Leukemia & Lymphoma. 2021;Online ahead of print. doi: 10.1080/10428194.2021.1907378.

Christian S, Arain S, Patel P, Khan I, Calip GS, Agrawal V, Sweiss K, Griffin SP, Cahill K, Konig H, Esen A, Shergill A, Odenike O, Stock W, Quigley JG. A multi-institutional comparison of mitoxantrone, etoposide, and cytarabine vs high-dose cytarabine and mitoxantrone therapy for patients with relapsed or refractory acute myeloid leukemia. American Journal of Hematology. 2020;95(8):937-43. doi: 10.1002/ajh.25838.

Chen F, Wu X, Niculite C, Gilca M, Petrusca D, Rogozea A, Rice S, Guo B, Griffin SP, Calin GA, Boswell HS, Konig H. Classic and targeted anti-leukaemic agents interfere with the cholesterol biogenesis metagene in acute myeloid leukaemia: Therapeutic implications. Journal of Cellular and Molecular Medicine. 2020;24(13):7378-92. doi: 10.1111/jcmm.15339.

Agrawal A, Ranganath P, Ervin KD, Schmidt CA, Cox EA, Nelson RP, Schwartz JE, Abu Zaid M, Abonour R, Robertson MJ, Brinda BJ, Griffin SP, Thakrar TC, Farag SS. Effect of Sirolimus levels between days 11 and 20 after allogeneic stem cell transplantation on the risk of hepatic sinusoidal obstruction syndrome. Bone Marrow Transplantation. 2020;Online ahead of print. doi: 10.1038/s41409-020-0987-1.

Hickey EL, Clemons B, Griffin SP, Cox J, Sutphin S, Ramlal R, Benitez L. Multi-center Evaluation of Arsenic Trioxide Dosing in Obese Patients with Low-Intermediate Risk Acute Promyelocytic Leukemia. Leukemia & Lymphoma. 2019;60(14):3557-60. doi: 10.1080/10428194.2019.1639163.

Griffin SP, Wheeler SE, Wiggins LE, Murthy HS, Hsu JW, Richards AI. Pharmacokinetic and Clinical Outcomes When Ideal Body Weight is Used to Dose Busulfan in Obese Hematopoietic Stem Cell Transplant Recipients. Bone Marrow Transplantation. 2019;54(2):218-225. doi: 10.1038/s41409-018-0240-3.

Griffin SP, Nelson JE. Impact of a Clinical Solid Organ Transplant Pharmacist on Tacrolimus Nephrotoxicity, Therapeutic Drug Monitoring, and Institutional Revenue Generation in Adult Kidney Transplant Recipients. Progress in Transplantation. 2016; 26(4):314-321. doi: 10.1177/1526924816667950.

2023, Hematology/Oncology Pharmacy Association (HOPA) Early Career Research Award Primary investigator Risk-ADAPTed Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation Correlative PharmacoKinetic Study (ADAPT-PK). USD $49,999.89.

2022, UCI Genetic Epidemiology Research Institute, All of Us Data Funding Opportunity Co-investigator (Primary Investigator: Nana Entsuah) Psychological Distress and Medication Misuse during COVID-19 across Racial-ethnic Minority Identities (PICAR). USD $2,500.

2021, Hematology/Oncology Pharmacy Association (HOPA) Research Award Co-investigator (Primary Investigator: Alex Chan) Patient-Reported Outcomes (PRO)-driven pharmacy education In ethnic minOrity patients Receiving antIcancer TherapIES (PRIORITIES). USD $38,116.

American Society for Transplantation and Cellular Therapy

Hematology/Oncology Pharmacy Association

American College of Clinical Pharmacy

California Society of Health-System Pharmacists

PGY2 Oncology Pharmacy Resident
University of Florida Health Shands Hospital 2015—2016

PGY1 Pharmacy Resident
University of Florida Health Shands Hospital 2014—2015

Chao Family Comprehensive Cancer Center

Link to this profile
https://faculty.uci.edu/profile/?facultyId=7002

Last updated
08/28/2026